The biphasic and age-dependent impact of Klotho on hallmarks of aging and skeletal muscle function

  1. Zachary Clemens
  2. Sruthi Sivakumar
  3. Abish Pius
  4. Amrita Sahu
  5. Sunita Shinde
  6. Hikaru Mamiya
  7. Nathaniel Luketich
  8. Jian Cui
  9. Purushottam Dixit
  10. Joerg D Hoeck
  11. Sebastian Kreuz
  12. Michael Franti
  13. Aaron Barchowsky
  14. Fabrisia Ambrosio  Is a corresponding author
  1. University of PIttsburgh, United States
  2. University of Pittsburgh, United States
  3. University of Florida, United States
  4. Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
  5. Boehringer Ingelheim Pharma GmbH & Co. KG, United States

Abstract

Aging is accompanied by disrupted information flow, resulting from accumulation of molecular mistakes. These mistakes ultimately give rise to debilitating disorders including skeletal muscle wasting, or sarcopenia. To derive a global metric of growing 'disorderliness' of aging muscle, we employed a statistical physics approach to estimate the state parameter, entropy, as a function of genes associated with hallmarks of aging. Escalating network entropy reached an inflection point at old age, while structural and functional alterations progressed into oldest-old age. To probe the potential for restoration of molecular 'order' and reversal of the sarcopenic phenotype, we systemically overexpressed the longevity protein, Klotho, via AAV. Klotho overexpression modulated genes representing all hallmarks of aging in old and oldest-old mice, but pathway enrichment revealed directions of changes were, for many genes, age-dependent. Functional improvements were also age-dependent. Klotho improved strength in old mice, but failed to induce benefits beyond the entropic tipping point.

Data availability

Sequencing data has been deposited in GEO accession: GSE156343.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Zachary Clemens

    Department of Physical Medicine and Rehabilitation, University of PIttsburgh, Pittsburgh, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2230-9151
  2. Sruthi Sivakumar

    Department of BIoengineering, University of Pittsburgh, Pittsburgh, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0649-8551
  3. Abish Pius

    Department of Physical Medicine and Rehabilitation, Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, United States
    Competing interests
    No competing interests declared.
  4. Amrita Sahu

    Department of PHysical Medicine and Rehabilitation, University of PIttsburgh, PIttsburgh, United States
    Competing interests
    No competing interests declared.
  5. Sunita Shinde

    Department of Physical Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, United States
    Competing interests
    No competing interests declared.
  6. Hikaru Mamiya

    Department of Bioengineering, University of Pittsburgh, Pittsburgh, United States
    Competing interests
    No competing interests declared.
  7. Nathaniel Luketich

    Department of BIoengineering, University of Pittsburgh, Pittsburgh, United States
    Competing interests
    No competing interests declared.
  8. Jian Cui

    Department of Computational and Systems Biology, University of PIttsburgh, Pittsburgh, United States
    Competing interests
    No competing interests declared.
  9. Purushottam Dixit

    University of Florida, Gainesville, United States
    Competing interests
    No competing interests declared.
  10. Joerg D Hoeck

    Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany
    Competing interests
    Joerg D Hoeck, J.H. is an employee of Boehringer INgelheim Pharmaceutical Company.
  11. Sebastian Kreuz

    Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany
    Competing interests
    Sebastian Kreuz, S.K. is an employee of Boehringer INgelheim Pharmaceutical Company.
  12. Michael Franti

    Boehringer Ingelheim Pharma GmbH & Co. KG, Boston, United States
    Competing interests
    Michael Franti, M.F. is an employee of Boehringer Ingelheim Pharmaceutical Company.
  13. Aaron Barchowsky

    Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1268-8159
  14. Fabrisia Ambrosio

    Department of Physical Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, United States
    For correspondence
    ambrosiof@upmc.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5497-5968

Funding

National Institute on Aging (R01AG052978)

  • Fabrisia Ambrosio

National Institute on Aging (R01AG061005)

  • Fabrisia Ambrosio

Boehringer Ingelheim

  • Fabrisia Ambrosio

J.H., S.K. and M.F. are employees of Boehringer Ingelheim Pharmaceutical Company. They contributed to development, testing and validation of the AAV-Klotho vector, as well as the overall study design.

Ethics

Animal experimentation: All animal experiments were performed with prior approval from the Institutional Animal Care and Use Committee of the University of Pittsburgh. These experiments were conducted in accordance with protocol 17080802 (University of Pittsburgh ARO: IS00017744). All surgeries and invasive procedures were performed under isoflurane anesthesia, with painkillers administered afterwards. Every effort was made to minimize suffering.

Copyright

© 2021, Clemens et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,154
    views
  • 682
    downloads
  • 35
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Zachary Clemens
  2. Sruthi Sivakumar
  3. Abish Pius
  4. Amrita Sahu
  5. Sunita Shinde
  6. Hikaru Mamiya
  7. Nathaniel Luketich
  8. Jian Cui
  9. Purushottam Dixit
  10. Joerg D Hoeck
  11. Sebastian Kreuz
  12. Michael Franti
  13. Aaron Barchowsky
  14. Fabrisia Ambrosio
(2021)
The biphasic and age-dependent impact of Klotho on hallmarks of aging and skeletal muscle function
eLife 10:e61138.
https://doi.org/10.7554/eLife.61138

Share this article

https://doi.org/10.7554/eLife.61138

Further reading

    1. Computational and Systems Biology
    George N Bendzunas, Dominic P Byrne ... Natarajan Kannan
    Research Article

    In eukaryotes, protein kinase signaling is regulated by a diverse array of post-translational modifications, including phosphorylation of Ser/Thr residues and oxidation of cysteine (Cys) residues. While regulation by activation segment phosphorylation of Ser/Thr residues is well understood, relatively little is known about how oxidation of cysteine residues modulate catalysis. In this study, we investigate redox regulation of the AMPK-related brain-selective kinases (BRSK) 1 and 2, and detail how broad catalytic activity is directly regulated through reversible oxidation and reduction of evolutionarily conserved Cys residues within the catalytic domain. We show that redox-dependent control of BRSKs is a dynamic and multilayered process involving oxidative modifications of several Cys residues, including the formation of intramolecular disulfide bonds involving a pair of Cys residues near the catalytic HRD motif and a highly conserved T-loop Cys with a BRSK-specific Cys within an unusual CPE motif at the end of the activation segment. Consistently, mutation of the CPE-Cys increases catalytic activity in vitro and drives phosphorylation of the BRSK substrate Tau in cells. Molecular modeling and molecular dynamics simulations indicate that oxidation of the CPE-Cys destabilizes a conserved salt bridge network critical for allosteric activation. The occurrence of spatially proximal Cys amino acids in diverse Ser/Thr protein kinase families suggests that disulfide-mediated control of catalytic activity may be a prevalent mechanism for regulation within the broader AMPK family.

    1. Computational and Systems Biology
    2. Genetics and Genomics
    Fangluo Chen, Dylan C Sarver ... G William Wong
    Research Article

    Obesity is a major risk factor for type 2 diabetes, dyslipidemia, cardiovascular disease, and hypertension. Intriguingly, there is a subset of metabolically healthy obese (MHO) individuals who are seemingly able to maintain a healthy metabolic profile free of metabolic syndrome. The molecular underpinnings of MHO, however, are not well understood. Here, we report that CTRP10/C1QL2-deficient mice represent a unique female model of MHO. CTRP10 modulates weight gain in a striking and sexually dimorphic manner. Female, but not male, mice lacking CTRP10 develop obesity with age on a low-fat diet while maintaining an otherwise healthy metabolic profile. When fed an obesogenic diet, female Ctrp10 knockout (KO) mice show rapid weight gain. Despite pronounced obesity, Ctrp10 KO female mice do not develop steatosis, dyslipidemia, glucose intolerance, insulin resistance, oxidative stress, or low-grade inflammation. Obesity is largely uncoupled from metabolic dysregulation in female KO mice. Multi-tissue transcriptomic analyses highlighted gene expression changes and pathways associated with insulin-sensitive obesity. Transcriptional correlation of the differentially expressed gene (DEG) orthologs in humans also shows sex differences in gene connectivity within and across metabolic tissues, underscoring the conserved sex-dependent function of CTRP10. Collectively, our findings suggest that CTRP10 negatively regulates body weight in females, and that loss of CTRP10 results in benign obesity with largely preserved insulin sensitivity and metabolic health. This female MHO mouse model is valuable for understanding sex-biased mechanisms that uncouple obesity from metabolic dysfunction.